Appendix 4C Quarterly Report & Company Update
150422_Appendix 4C Quarterly Report & Company Update
150422_Appendix 4C Quarterly Report & Company Update
150331_Joint Patent with Japanese Corporation now published
150324_Final Patient in Cohort Demonstrates Tumour Marker Reduction
150317_Completion of Lowest Dose Cohort in Human Cancer Trial
150316_PharmAust completes $3.14m Share Placement oversubscribed
150319_PharmAust Shareholder Presentation – March 2015
[pdf-embedder url=”https://www.pharmaust.com/wp-content/uploads/2015/03/150306_American-Assoc-for-Cancer-accepts-Late-Breaking-Abstract.pdf” title=”150306_American Assoc for Cancer accepts Late-Breaking Abstract”
150209_Human Trial Prelim Results Shows Reduction in Tumour Markers